Curbstone Financial Management Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Buy |
47,027
+3,730
| +9% | +$97.6K | 0.19% | 108 |
|
|
2026
Q1 | $1.22M | Sell |
43,297
-1,500
| -3% | -$39.9K | 0.23% | 91 |
|
|
2025
Q4 | $1.12M | Sell |
44,797
-4,848
| -10% | -$122K | 0.21% | 96 |
|
|
2025
Q3 | $1.26M | Sell |
49,645
-3,150
| -6% | -$77.7K | 0.24% | 92 |
|
|
2025
Q2 | $1.28M | Sell |
52,795
-5,748
| -10% | -$134K | 0.26% | 88 |
|
|
2025
Q1 | $1.48M | Buy |
58,543
+1,992
| +4% | +$52.1K | 0.31% | 77 |
|
|
2024
Q4 | $1.5M | Sell |
56,551
-1,408
| -2% | -$38.2K | 0.32% | 77 |
|
|
2024
Q3 | $1.68M | Sell |
57,959
-3,814
| -6% | -$111K | 0.36% | 74 |
|
|
2024
Q2 | $1.73M | Buy |
61,773
+50
| +0.1% | +$1.38K | 0.38% | 66 |
|
|
2024
Q1 | $1.71M | Buy |
61,723
+1,450
| +2% | +$40.2K | 0.37% | 74 |
|
|
2023
Q4 | $1.74M | Buy |
60,273
+500
| +0.8% | +$15.1K | 0.39% | 66 |
|
|
2023
Q3 | $1.98M | Sell |
59,773
-200
| -0.3% | -$7.07K | 0.49% | 56 |
|
|
2023
Q2 | $2.2M | Sell |
59,973
-220
| -0.4% | -$8.56K | 0.52% | 54 |
|
|
2023
Q1 | $2.46M | Buy |
60,193
+158
| +0.3% | +$6.82K | 0.6% | 46 |
|
|
2022
Q4 | $3.08M | Buy |
60,035
+170
| +0.3% | +$8.15K | 0.77% | 37 |
|
|
2022
Q3 | $2.62M | Sell |
59,865
-86
| -0.1% | -$4.18K | 0.65% | 41 |
|
|
2022
Q2 | $3.14M | Sell |
59,951
-5,950
| -9% | -$303K | 0.73% | 36 |
|
|
2022
Q1 | $3.41M | Buy |
65,901
+200
| +0.3% | +$10.4K | 0.63% | 44 |
|
|
2021
Q4 | $3.88M | Sell |
65,701
-3,002
| -4% | -$149K | 0.69% | 42 |
|
|
2021
Q3 | $2.96M | Buy |
68,703
+1,216
| +2% | +$53.9K | 0.56% | 49 |
|
|
2021
Q2 | $2.64M | Buy |
67,487
+800
| +1% | +$31.1K | 0.5% | 57 |
|
|
2021
Q1 | $2.42M | Sell |
66,687
-800
| -1% | -$28.4K | 0.48% | 58 |
|
|
2020
Q4 | $2.48M | Sell |
67,487
-35
| -0.1% | -$1.28K | 0.52% | 53 |
|
|
2020
Q3 | $2.35M | Buy |
67,522
+895
| +1% | +$31.4K | 0.56% | 49 |
|
|
2020
Q2 | $2.07M | Buy |
66,627
+264
| +0.4% | +$8.97K | 0.54% | 52 |
|
|
2020
Q1 | $2.06M | Sell |
66,363
-1,739
| -3% | -$59.3K | 0.62% | 45 |
|
|
2019
Q4 | $2.53M | Buy |
68,102
+896
| +1% | +$31.9K | 0.6% | 49 |
|
|
2019
Q3 | $2.29M | Buy |
67,206
+411
| +0.6% | +$14.9K | 0.59% | 49 |
|
|
2019
Q2 | $2.75M | Sell |
66,795
-747
| -1% | -$29.7K | 0.72% | 42 |
|
|
2019
Q1 | $2.72M | Buy |
67,542
+4,200
| +7% | +$168K | 0.74% | 38 |
|
|
2018
Q4 | $2.62M | Buy |
63,342
+25
| +0% | +$1.04K | 0.79% | 36 |
|
|
2018
Q3 | $2.65M | Sell |
63,317
-173
| -0.3% | -$6.66K | 0.69% | 43 |
|
|
2018
Q2 | $2.19M | Buy |
63,490
+1,107
| +2% | +$37.8K | 0.6% | 48 |
|
|
2018
Q1 | $2.1M | Buy |
62,383
+31,157
| +100% | +$1.07M | 0.59% | 49 |
|
|
2017
Q4 | $1.07M | Sell |
31,226
-30,331
| -49% | -$1.03M | 0.59% | 49 |
|
|
2017
Q3 | $2.08M | Buy |
61,557
+32,040
| +109% | +$1.03M | 0.6% | 52 |
|
|
2017
Q2 | $941K | Buy |
29,517
+614
| +2% | +$19.4K | 0.57% | 54 |
|
|
2017
Q1 | $938K | Sell |
28,903
-1,159
| -4% | -$36.5K | 0.58% | 52 |
|
|
2016
Q4 | $926K | Sell |
30,062
-29,642
| -50% | -$905K | 0.58% | 51 |
|
|
2016
Q3 | $1.92M | Sell |
59,704
-896
| -1% | -$30K | 0.62% | 46 |
|
|
2016
Q2 | $2.02M | Sell |
60,600
-105
| -0.2% | -$3.35K | 0.68% | 42 |
|
|
2016
Q1 | $1.71M | Buy |
60,705
+4,479
| +8% | +$128K | 0.57% | 49 |
|
|
2015
Q4 | $1.72M | Buy |
56,226
+27,956
| +99% | +$879K | 0.59% | 48 |
|
|
2015
Q3 | $842K | Buy |
28,270
+421
| +2% | +$13.5K | 0.61% | 45 |
|
|
2015
Q2 | $886K | Buy |
27,849
+100
| +0.4% | +$3.26K | 0.59% | 52 |
|
|
2015
Q1 | $916K | Buy |
27,749
+1,668
| +6% | +$53K | 0.62% | 46 |
|
|
2014
Q4 | $771K | Buy |
26,081
+2,377
| +10% | +$68.2K | 0.59% | 50 |
|
|
2014
Q3 | $665K | Hold |
23,704
| – | – | 0.52% | 55 |
|
|
2014
Q2 | $668K | Sell |
23,704
-607
| -2% | -$17.3K | 0.51% | 58 |
|
|
2014
Q1 | $741K | Buy |
+24,311
| New | +$725K | 0.6% | 49 |
|
Other funds holding PFE
Curbstone Financial Management Corp's PFE Position: Q2 2026 in Review
Curbstone Financial Management Corp increased its Pfizer (PFE) stake by 8.6% in Q2 2026, buying an estimated $97.6K and bringing the position to 47,027 shares worth $1.13M. The position accounts for 0.19% of the portfolio, ranked #108.
Curbstone Financial Management Corp first reported a position in PFE in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.88M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Curbstone Financial Management Corp held 47,027 shares of Pfizer worth $1.13M as of Q2 2026.
- Curbstone Financial Management Corp bought 3,730 Pfizer shares in Q2 2026, an estimated $97.6K.
- Pfizer made up 0.19% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #108 holding.
- Curbstone Financial Management Corp first reported a position in Pfizer in Q1 2014 and has held it in 50 quarters since.
- Curbstone Financial Management Corp's Pfizer position peaked at $3.88M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.